Patents by Inventor UPASANA BANERJEE

UPASANA BANERJEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Itraconazole analogues and methods of use thereof
    Patent number: 9839636
    Abstract: Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 12, 2017
    Assignee: UNIVERSITY OF CONNECTICUT
    Inventors: Matthew Kyle Hadden, Upasana Banerjee
  • ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF
    Publication number: 20170209436
    Abstract: Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Inventors: MATTHEW KYLE HADDEN, UPASANA BANERJEE
  • Itraconazole analogues and methods of use thereof
    Patent number: 9650365
    Abstract: Disclosed herein are analogs of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: May 16, 2017
    Assignee: UNIVERSITY OF CONNECTICUT
    Inventors: Matthew Kyle Hadden, Upasana Banerjee
  • ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF
    Publication number: 20160340346
    Abstract: Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
    Type: Application
    Filed: August 1, 2016
    Publication date: November 24, 2016
    Inventors: MATTHEW KYLE HADDEN, UPASANA BANERJEE